Who is sponsoring NCT03730701?

NCT03730701 is sponsored by Emelie Malstam.

What drugs are being tested in NCT03730701?

Interventions in NCT03730701: Prevention program for stroke.

What condition does NCT03730701 study?

NCT03730701 studies Non-Communicable Diseases, Stroke, Cardiovascular Risk Factor.

Is NCT03730701 still recruiting?

NCT03730701 is currently completed. Last updated 21 March 2023.

Last reviewed 2023-03-21 · How we verify

NCT03730701

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Make my Day - Primary Prevention of Stroke

Completed NA Last updated 21 March 2023

What this trial tests

NA trial testing Prevention program for stroke in Non-Communicable Diseases in 30 participants. Completed in 31 December 2020.

Timeline

6 August 2019

Primary endpoint
30 November 2020

31 December 2020

Quick facts

Lead sponsor	Emelie Malstam
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	30
Start date	6 August 2019
Primary completion	30 November 2020
Estimated completion	31 December 2020
Sites	1 location across Sweden

Drugs / interventions tested

Prevention program for stroke

Conditions studied

Non-Communicable Diseases — all drugs for Non-Communicable Diseases →
Stroke — all drugs for Stroke →
Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →

Sponsor

Emelie Malstam

Who can join

Adults 45 to 75, any sex, with Non-Communicable Diseases or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the feasibility of a digital, person-centered stroke prevention program with a focus on primary prevention. The program is aiming to enable lifestyle change and to promote healthy activity patterns to decrease risk factors for stroke and in that way prevent future stroke.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Primary prevention of stroke: randomised controlled pilot trial protocol on engaging everyday activities promoting health.
Patomella AH, Guidetti S, Mälstam E, Eriksson C, et al · · 2019 · cited 9× · PMID 31678952 · DOI 10.1136/bmjopen-2019-031984
The Feasibility of Make My Day-A Randomized Controlled Pilot Trial of a Stroke Prevention Program in Primary Healthcare.
Mälstam E, Asaba E, Åkesson E, Guidetti S, et al · · 2023 · cited 8× · PMID 37835098 · DOI 10.3390/ijerph20196828
Implementation of Stroke Prevention Intervention Make My Day in Swedish Primary Healthcare.
Mälstam E, Asaba E, Åkesson E, Guidetti S, et al · · 2026 · PMID 41784072 · DOI 10.1177/00084174261421395

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03730701 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Emelie Malstam
Last refreshed: 21 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03730701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing